Allegretti, M., Fabi, A., Buglioni, S., Martayan, A., Conti, L., Pescarmona, E., . . . Giacomini, P. (2018). Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations. J Exp Clin Cancer Res.
Čikaški stil citiranjaAllegretti, Matteo, Alessandra Fabi, Simonetta Buglioni, Aline Martayan, Laura Conti, Edoardo Pescarmona, Gennaro Ciliberto, i Patrizio Giacomini. "Tearing Down the Walls: FDA Approves Next Generation Sequencing (NGS) Assays for Actionable Cancer Genomic Aberrations." J Exp Clin Cancer Res 2018.
MLA način citiranjaAllegretti, Matteo, et al. "Tearing Down the Walls: FDA Approves Next Generation Sequencing (NGS) Assays for Actionable Cancer Genomic Aberrations." J Exp Clin Cancer Res 2018.